ALERT: The Rosen Law Firm Announces Securities Fraud Class

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ALERT: The Rosen Law Firm Announces Securities Fraud Class Action Against Doral Financial Corp. -- DRL

NEW YORK, June 5, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. announces that a class action lawsuit has been filed on behalf of purchasers of Doral Financial Corp (NYSE: DRL ) securities between April 2, 2012 and May 1, 2014, inclusive, seeking to recover damages for violations of the federal securities laws.

To join the Doral class action, visit the firm's website at http://rosenlegal.com , or call Phillip Kim, Esq. or Jonathan Horne, Esq., toll-free, at 866-767-3653; you may also email at pkim@rosenlegal.com or jhorne@rosenlegal.com for information on the class action. The lawsuit is pending in the U.S. District Court for the District of Puerto Rico.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, throughout the class period defendants issued materially false and misleading statements regarding Doral's true financial condition, and failed to disclose adverse facts, including that (a) because of errors in its mathematical models and incorrect data, Doral had greatly underestimated the amount it must charge as provision for loan and lease losses against earnings, and (b) Doral kept on its books a $229 million tax receivable it was not actually owed.

On March 18, 2014, Doral announced that it had understated its provision for loan and lease losses because of material deficiencies in its internal controls over financial reporting. On this news, the price of Doral common stock decreased from $12.30 to $11.17 per share. On March 21, 2014, Doral announced an increased provision of ALLL, a net loss for the fourth quarter of 2013, and that it was forced to restate the financial statements for the third quarter of 2013. On this news, Doral common stock dropped from $11.55 to $10.76 per share. Then on May 1, 2014, the Company announced that $226 million in tax receivables from the Government of Puerto Rico from purported prior-year tax overpayments could no longer be counted as Tier 1 regulatory capital. The following day, Doral common stock fell 62%, from $9.82 to $3.73. Finally, on June 2, 2014, the Company announced that the Federal Reserve Bank of New York has advised it to classify the tax receivable as a loss and write off the asset. On this news, Doral common stock declined from $3.56 to $2.97 per share.

If you wish to serve as lead plaintiff, you must move the Court no later than July 14, 2014. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Jonathan Horne, Esq. of The Rosen Law Firm, toll-free, at 866-767-3653, or via e-mail at pkim@rosenlegal.com  or jhorne@rosenlegal.com . You may also visit the firm's website at http://rosenlegal.com .

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Laurence M. Rosen, Esq. Phillip Kim, Esq. Jonathan Horne, Esq. The Rosen Law Firm P.A. 275 Madison Avenue 34th Floor New York, New York 10016 Tel: (212) 686-1060 Toll Free: 1-866-767-3653 Fax: (212) 202-3827 www.rosenlegal.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ardelyx Securities Fraud Suit: Key Investor Moves

Updated Category News Views 5

Fraud Allegations: Ardelyx Under the Microscope Looks like Ardelyx has found itself neck-deep in trouble, facing a class action lawsuit over alleged securities fraud. This isn't just a storm in a teacup. We're talking about accusations of false and misleading statements tied to their commercial performance—statements that might have left investors holding the bag with...

Continue Reading
Raken Debuts Change Orders: A Game-Changer for Builds

Updated Category News Views 4

Construction Gets a Streamlined Boost with Raken's New Tool In construction, chaos often partners seamlessly with progress. But Raken is stepping in to shake things up a bit. This isn’t just another run-of-the-mill software update; this is Raken flexing its muscles in the construction tech arena. They’ve rolled out Change Orders, enhancing their project management...

Continue Reading
PrideStaff: 8 Years Strong on Franchise Times Top 400

Updated Category News Views 4

Where PrideStaff Stands in the Franchise Landscape Here's something the staffing world can't ignore: PrideStaff nailed it again, landing among the giants on the Franchise Times Top 400 for the eighth straight year. Sitting at number 217, this ain't just a lucky streak—this is a sustained homerun, my friends. Consistency Is Key, And They're Holding It Consider this...

Continue Reading
Ajman Tourism Department Hits Internal Audit Milestone

Updated Category News Views 4

A Nod to Standards in Ajman's Tourism Department Folks, it's not every day you see a government department get this kind of spotlight in the internal audit arena, yet here we are. The Ajman Department of Tourism, Culture and Media has snagged Full Conformance with Internal Audit Quality Standards. That’s not just some random feather in their cap but a signal flare in...

Continue Reading
Teamsters Secure Landmark Deal for SF Parking Workers

Updated Category News Views 4

Major Win for San Francisco's Parking Professionals Parking lots and garages across San Francisco might not be the first places you’d look for labor triumphs, but that’s exactly what almost 1,000 members of Teamsters Local 665 have achieved. Under a newly ratified four-year master contract, these parking pros snagged one of the richest deals the industry has seen. A...

Continue Reading
Lupin Secures FDA Nod for Key Injectable Drug

Updated Category News Views 4

Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...

Continue Reading
Steel Dynamics Gears Up for Q3 2026 Earnings Update

Updated Category News Views 7

Steel Dynamics Preps for Key Earnings Report Folks, we're staring down the barrel of another quarterly earnings report from Steel Dynamics, Inc., and you can bet this one is gonna have plenty of eyes glued. October 19th, 2026, that's when they'll peel back the curtain on how they fared in Q3. Now, buckle up, because this isn't just a numbers game—it’s a snapshot of...

Continue Reading
Hexaware Teams with Anthropic for Game-Changing AI Move

Updated Category News Views 4

A Bold AI Partnership on the Horizon Mutual back-slapping or a deal with authentic grit? Hexaware’s latest tango with Anthropic might just be the jolt enterprises need. Announced under the flickering fluorescent lights of Mumbai, London, and Iselin, Hexaware’s multi-year partnership with Anthropic thrusts Claude, their razor-sharp AI, right into the mix of...

Continue Reading
CME Group Unveils First Baseball Futures Market

Updated Category News Views 6

A New Pitch in the Financial Ballpark Alright, listen up: CME Group is stepping up to the plate with a game-changer. They’re rolling out the world’s first baseball futures, launching October 12, assuming regulators give the green light. Now, this isn’t just some novelty act; it’s based on the solid groundwork of their FutureSports Performance Indexes (CME FSPI),...

Continue Reading
Mexico's Beaches Shine in 2026 Best America Rankings

Updated Category News Views 5

Mexican Shores Turning Heads in 2026 This isn’t just another wave in tourism news; it’s a tidal shift towards Mexico’s sizzling beaches claiming some prime spots on the global travel stage. If you’ve got an eye for tourism dynamics, listen up because Mexico’s sun-soaked shores just snagged six spots among the top 20 beaches in the Americas, according to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Join Sensorion's Upcoming Webconference for Retail Investors

Updated Category News Views 49

Unlocking Hearing Health: Sensorion's Webconference for Retail Investors Sensorion, a trailblazer in the clinical-stage biotech space, is making waves in hearing loss therapy. They’ve announced a dedicated webconference that’s exclusively for retail shareholders—yeah, those everyday investors looking to get the lowdown on where their money's going. The Lowdown on...

Continue Reading
Mantle Network Revolutionizes Crypto with ZK Validity Rollup

Updated Category News Views 93

Transforming the Crypto Landscape with ZK Rollups Mantle Network is making significant strides in the realm of blockchain technology by advancing its technical roadmap. Recently, the network established a pioneering alliance with Succinct, positioning it as the highest total value locked (TVL) ZK validity rollup within the Ethereum layer 2 ecosystem. This transition marks...

Continue Reading
Columbus Implements Share Buyback Program for Investor Value

Updated Category News Views 146

Overview of Columbus A/S Share Buyback Program Columbus A/S is actively engaging in a share buyback initiative to support its investors and enhance the overall value of the company. Announced earlier, the program permits the corporation to repurchase shares worth up to DKK 16 million from June to March the following year. Details of Recent Transactions Timeframe of...

Continue Reading
Prospect Capital Plans Fiscal Earnings Call Ahead

Updated Category News Views 87

Prospect Capital Announces Earnings Call for Fiscal Year Prospect Capital Corporation (NASDAQ: PSEC) has revealed plans for an upcoming earnings release and conference call regarding its fiscal year that ended on June 30, 2024. This report will be submitted to the Securities and Exchange Commission, providing a detailed overview of the company's financial performance....

Continue Reading
10x Genomics Unveils Affordable Solutions for Single Cell Analysis

Updated Category News Views 90

Innovations in Single Cell Analysis by 10x Genomics At the recent Human Cell Atlas General Meeting, 10x Genomics, Inc. (NASDAQ: TXG) unveiled groundbreaking plans that promise to revolutionize single cell analysis. This exciting announcement is a significant step towards making advanced single cell technology accessible to researchers across the globe. Affordable...

Continue Reading